Philip G. Murphy

3.1k citations

87 papers · 2.2k indexed · h-index 29

Pulmonary and Respiratory Medicine top 5%
Molecular Biology
Infectious Diseases top 5%
Epidemiology top 10%
Molecular Medicine top 2%

Co-authors: John E. Moore Catherine M. Greene Noel G. McElvaney Siobhán McClean M. Callaghan Shane O’Neill Clifford C. Taggart Emma Caraher
Topics: Cystic Fibrosis Research Advances (26 papers)Salmonella and Campylobacter epidemiology (13 papers)Antimicrobial Resistance in Staphylococcus (12 papers)
Cited by: Molecular Medicine Endocrinology Infectious Diseases
Journals: Nature The Journal of Immunology PLoS ONE
Partner nations: Ireland United Kingdom United States

In The Last Decade

Philip G. Murphy

85 papers receiving 2.1k citations

Peers

Countries citing papers authored by Philip G. Murphy

Since Specialization

Citations

This map shows the geographic impact of Philip G. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip G. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip G. Murphy more than expected).

Fields of papers citing papers by Philip G. Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip G. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip G. Murphy. The network helps show where Philip G. Murphy may publish in the future.

Co-authorship network of co-authors of Philip G. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Philip G. Murphy. A scholar is included among the top collaborators of Philip G. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip G. Murphy. Philip G. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Aspergillus fumigatus Supernatants Disrupt Bronchial Epithelial Monolayers: Potential Role for Enhanced Invasion in Cystic Fibrosis 2023 ·Journal of Fungi ·Katie Dunne,(unknown),Siobhán McClean,Seán Doyle,Thomas R. Rogers,Philip G. Murphy,J. A. A. Renwick	3
2	Combination antibiotics against Pseudomonas aeruginosa, representing common and rare cystic fibrosis strains from different Irish clinics 2018 ·Heliyon ·Priya Kapoor,Philip G. Murphy	11
3	The basophil surface marker CD203c identifies Aspergillus species sensitization in patients with cystic fibrosis 2015 ·Journal of Allergy and Clinical Immunology ·Bojana Mirković,Gillian Lavelle,Ahmed Abdul Azim,(unknown),(unknown),Kevin Molloy,Yaël Gernez,Katie Dunne,J. A. A. Renwick,Philip G. Murphy,Richard B. Moss,Catherine M. Greene,Cedric Gunaratnam,Sanjay H. Chotirmall,Noel G. McElvaney	42
4	Screening for Corynebacterium diphtheriae and Corynebacterium ulcerans in patients with upper respiratory tract infections 2007-2008: a multicentre European study 2013 ·STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) ·Karen Wagner,Joanne White,Shona Neal,Natasha S. Crowcroft,(unknown),(unknown),Irina Lucenko,(unknown),(unknown),(unknown),(unknown),Jaana Vuopio,Christina von Hunolstein,Philip G. Murphy,Nick Andrews,A Efstratiou	6
5	The Effect of Aspergillus fumigatus Infection on Vitamin D Receptor Expression in Cystic Fibrosis 2012 ·American Journal of Respiratory and Critical Care Medicine ·(unknown),Sanjay H. Chotirmall,J. A. A. Renwick,Tidi Hassan,Teck Boon Low,Gudmundur Bergsson,(unknown),Kathleen Bennett,Katie Dunne,Catherine M. Greene,Cedric Gunaratnam,Kevin Kavanagh,(unknown),Philip G. Murphy,Emer P. Reeves,Noel G. McElvaney	83
6	Vitamin D receptor agonists inhibit pro-inflammatory cytokine production from the respiratory epithelium in cystic fibrosis 2011 ·Journal of Cystic Fibrosis ·Paul McNally,(unknown),Gudmundur Bergsson,(unknown),Clifford C. Taggart,Luciano Adorini,Milan R. Uskoković,B. Elnazir,Philip G. Murphy,Peter Greally,Catherine M. Greene,Noel G. McElvaney	48
7	Reporting of meticillin-resistant and -susceptible Staphylococcus aureus on death certificates in Irish hospitals 2011 ·Journal of Hospital Infection ·(unknown),Marianne Fraher,Karen O’Connell,Jérôme Fennell,(unknown),Niamh O’Sullivan,Martin Cormican,Lynda Fenelon,Philip G. Murphy,Margaret M. Hannan	2
8	Screening for Corynebacterium diphtheriae and Corynebacterium ulcerans in patients with upper respiratory tract infections 2007–2008: a multicentre European study 2010 ·Clinical Microbiology and Infection ·Karen Wagner,Joanne White,Shona Neal,Natasha S. Crowcroft,(unknown),(unknown),Irina Lucenko,(unknown),(unknown),(unknown),(unknown),Jaana Vuopio,Christina von Hunolstein,Philip G. Murphy,Nick Andrews	38
9	LL-37 Complexation with Glycosaminoglycans in Cystic Fibrosis Lungs Inhibits Antimicrobial Activity, Which Can Be Restored by Hypertonic Saline 2009 ·The Journal of Immunology ·Gudmundur Bergsson,Emer P. Reeves,Paul McNally,Sanjay H. Chotirmall,Catherine M. Greene,Peter Greally,Philip G. Murphy,Shane O’Neill,Noel G. McElvaney	110
10	The effect of recombinant human lactoferrin on growth and the antibiotic susceptibility of the cystic fibrosis pathogen Burkholderia cepacia complex when cultured planktonically or as biofilms 2007 ·Journal of Antimicrobial Chemotherapy ·Emma Caraher,(unknown),Clifford C. Taggart,Philip G. Murphy,Siobhán McClean,M. Callaghan	24
11	Loss of Microbicidal Activity and Increased Formation of Biofilm Due to Decreased Lactoferrin Activity in Patients with Cystic Fibrosis 2004 ·The Journal of Infectious Diseases ·Mark P. Rogan,Clifford C. Taggart,Catherine M. Greene,Philip G. Murphy,Shane O’Neill,Noel G. McElvaney	136
12	Early detection of Pseudomonas aeruginosa – comparison of conventional versus molecular (PCR) detection directly from adult patients with cystic fibrosis (CF) 2004 ·Annals of Clinical Microbiology and Antimicrobials ·Jiru Xu,John E. Moore,Philip G. Murphy,B. Cherie Millar,J.S. Elborn	78
13	Haemophilus segnis: a rare cause of endocarditis 2003 ·Clinical Microbiology and Infection ·(unknown),B. Cherie Millar,Jianguo Xu,(unknown),Angelica Moran,Christopher G. Maloney,Brian Keogh,Philip G. Murphy,John E. Moore	13
14	Occurrence ofBurkholderia cepacia in the hospital environment 2002 ·Irish Journal of Medical Science (1971 -) ·John E. Moore,(unknown),Janet A. Buchanan,D.F. Gilpin,(unknown),Veronica L. Hall,Philip G. Murphy,J.S. Elborn	2
15	Prevalence of Thermophilic Campylobacter spp. in Ready-to-Eat Foods and Raw Poultry in Northern Ireland 2002 ·Journal of Food Protection ·John E. Moore,Thomas S. Wilson,D.R.A. Wareing,T. J. Humphrey,Philip G. Murphy	42
16	Investigation of infection with Campylobacter jejuni in a man with hypogammaglobulinaemia using PCR-single-strandedconformational polymorphism (PCR-SSCP) typing 2001 ·International Journal of Medical Microbiology ·John E. Moore,Martin D. Curran,D.R.A. Wareing,Andrew J. Fox,(unknown),(unknown),B. Cherie Millar,(unknown),Philip G. Murphy	8
17	Improved cultural detection of Burkholderia cepacia from sputum in patients with cystic fibrosis 2001 ·Journal of Clinical Pathology ·Ralph Wright,John E. Moore,(unknown),K Dunbar,M Dodd,(unknown),(unknown),Mary Crowe,Philip G. Murphy,Sharon J. Peacock,J.S. Elborn	15
18	Molecular identification of Acinetobacter sp. in a patient with culture-negative endocarditis 2000 ·Clinical Microbiology and Infection ·Patrick Mallon,B. Cherie Millar,John E. Moore,Philip G. Murphy,(unknown),(unknown),Mary Crowe	8
19	Parvovirus B19 Infection - Persistence and Genetic Variation 1995 ·Scandinavian Journal of Infectious Diseases ·Jonathan R. Kerr,Martin D. Curran,John E. Moore,Philip G. Murphy	24
20	Effects of salinity on uptake of DDT, DDE and ODD by fish 1970 ·Bulletin of Environmental Contamination and Toxicology ·Philip G. Murphy	17

About Philip G. Murphy

Philip G. Murphy is a scholar working on Molecular Medicine, Endocrinology and Infectious Diseases, having authored 87 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (26 papers), Salmonella and Campylobacter epidemiology (13 papers) and Antimicrobial Resistance in Staphylococcus (12 papers). The work is most often cited by research in Molecular Medicine (270 citations), Endocrinology (210 citations) and Infectious Diseases (445 citations). Philip G. Murphy has collaborated with scholars based in Ireland, United Kingdom and United States. Frequent co-authors include John E. Moore, Catherine M. Greene, Noel G. McElvaney, Siobhán McClean, M. Callaghan, Shane O’Neill, Clifford C. Taggart, Emma Caraher, J.S. Elborn and Paul McNally. Their work appears in journals such as Nature, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact